RecruitingNCT06400550
Identification of Metabolic Phenotypes Associated With Melanoma Metastasis
Sponsor
University of Texas Southwestern Medical Center
Enrollment
400 participants
Start Date
Aug 1, 2018
Study Type
OBSERVATIONAL
Conditions
Summary
The goal of this study is to observe metabolic features associated with human melanoma tumors.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study is investigating the metabolic (energy-processing) characteristics of melanoma (skin cancer) tumors to understand how tumors spread. Tissue samples will be collected during biopsies or surgeries that are already planned, so no additional procedures are required.
**You may be eligible if...**
- You are 18 or older, of any race or ethnic background
- You have a known or suspected malignant melanoma that requires surgical biopsy or excision as part of your regular care
**You may NOT be eligible if...**
- You are not a candidate for surgery
- You have poorly controlled diabetes
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06400550
Related Trials
High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial
NCT062987342 locations
Metronomic Cyclophosphamide With Pembrolizumab in Checkpoint Inhibitor Refractory Melanoma
NCT067715441 location
A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors
NCT069566907 locations
Phase II Study of Nivolumab in Combination With Relatlimab in Patients With Active Melanoma Brain Metastases
NCT057046471 location
Study of Alterations in Tumor Metabolism Associated With the Development of Immunotherapy Resistance in Melanoma
NCT053072891 location